GLOW LIFETECH CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.03 CAD | 0.00% |
|
+20.00% | -25.00% |
| Apr. 16 | Glow Lifetech Corp. announced that it expects to receive CAD 0.75 million in funding | CI |
| Apr. 12 | Glow Lifetech Corp. Announces CEO Changes | CI |
| Sales 2021 | - | Sales 2022 | - | Capitalization | 5.14M 7.03M |
|---|---|---|---|---|---|
| Net income 2021 | -11M -15.04M | Net income 2022 | -2M -2.74M | EV / Sales 2021 | - |
| Net cash position 2021 | 0.59 0.81 | Net Debt 2022 | 0.62 0.84 | EV / Sales 2022 | - |
| P/E ratio 2021 |
-1.18
x | P/E ratio 2022 |
-2.26
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 93.73% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 week | +20.00% | ||
| 6 months | -66.67% | ||
| Current year | -25.00% |
1 week
0.03
0.04
1 month
0.020.04
Current year
0.020.04
1 year
0.020.13
3 years
0.020.58
5 years
0.020.88
10 years
0.020.88
| Managers | Title | Age | Since |
|---|---|---|---|
Roberto Carducci
CEO | Chief Executive Officer | 37 | - |
Joshua Bald
DFI | Director of Finance/CFO | - | 21-09-30 |
Tom Glawdel
COO | Chief Operating Officer | 40 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Roberto Carducci
CEO | Chief Executive Officer | 37 | - |
Daniel Proska
BRD | Director/Board Member | - | 23-09-05 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 0.03 | -14.29% | 1,000 |
| 24-04-22 | 0.035 | +16.67% | 1,000 |
| 24-04-18 | 0.03 | +20.00% | 1,000 |
| 24-04-17 | 0.025 | 0.00% | 53,000 |
| 24-04-16 | 0.025 | -28.57% | 20,000 |
Delayed Quote Canadian Securities Exchange, April 23, 2024 at 09:40 am EDT
More quotes
Glow LifeTech Corp. is a Canada-based company, which is engaged in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals and cannabis extracts that make fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The Company has a partnership with a Health Canada licensed producer (MEDZ) for cannabis product manufacturing. It performs manufacturing services within a dedicated facility under the quality and compliance control of MEDZ. The Company operates its own equipment as a contractor of MEDZ and all products are released under MEDZ license. The Company has continued the build out and testing of this manufacturing facility.
Calendar
2024-04-28
- Q4 2023 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -25.00% | 1.35M | |
| +3.13% | 43.43B | |
| +47.30% | 41.69B | |
| +8.49% | 41.31B | |
| -10.82% | 27.14B | |
| +8.26% | 25.28B | |
| -23.69% | 18.47B | |
| +1.58% | 12.33B | |
| +32.83% | 12.59B | |
| +6.63% | 11.03B |
- Stock Market
- Equities
- GLOW Stock
